GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Other Current Receivables

AngioLab (XKRX:251280) Other Current Receivables : ₩72.3 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab Other Current Receivables?

AngioLab's Other Current Receivables for the quarter that ended in Dec. 2023 was ₩72.3 Mil.

AngioLab's quarterly Other Current Receivables increased from Dec. 2021 (₩3.71 Mil) to Dec. 2022 (₩23.60 Mil) and increased from Dec. 2022 (₩23.60 Mil) to Dec. 2023 (₩72.31 Mil).

AngioLab's annual Other Current Receivables increased from Dec. 2021 (₩3.71 Mil) to Dec. 2022 (₩23.60 Mil) and increased from Dec. 2022 (₩23.60 Mil) to Dec. 2023 (₩72.31 Mil).


AngioLab Other Current Receivables Historical Data

The historical data trend for AngioLab's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Other Current Receivables Chart

AngioLab Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial 139.98 137.10 3.71 23.60 72.31

AngioLab Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables Get a 7-Day Free Trial 139.98 137.10 3.71 23.60 72.31

AngioLab Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


AngioLab Other Current Receivables Related Terms

Thank you for viewing the detailed overview of AngioLab's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioLab (XKRX:251280) Business Description

Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines